<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282837</url>
  </required_header>
  <id_info>
    <org_study_id>Obesity Reclassification</org_study_id>
    <nct_id>NCT04282837</nct_id>
  </id_info>
  <brief_title>Machine Learning for Reclassification of Obesity</brief_title>
  <official_title>Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Third People's Hospital of Chengdu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai East Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to employ or develop computational modeling techniques for the
      precise reclassification of obesity into subgroups. Clinical features, risks of
      noncommunicable diseases, as well as weight loss effects of bariatric surgery will also be
      studied and compared within the subgroups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">June 20, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic classification of patients with obesity using machine learning</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic features in patients of different subgroups</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risks for noncommunicable disease in patients of different subgroups</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of bariatric surgery in patients of different subgroups</measure>
    <time_frame>1 year after bariatric surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">2495</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>NW</arm_group_label>
    <description>normal weight control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MHO</arm_group_label>
    <description>metabolic healthy obesity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LMO</arm_group_label>
    <description>hypometabolic obesity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMO-U</arm_group_label>
    <description>hypermetabolic obesity with hyperuricemia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMO-I</arm_group_label>
    <description>hypermetabolic obesity with hyperinsulinemia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AI classification of patients with obesity</intervention_name>
    <description>Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.</description>
    <arm_group_label>HMO-I</arm_group_label>
    <arm_group_label>HMO-U</arm_group_label>
    <arm_group_label>LMO</arm_group_label>
    <arm_group_label>MHO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with overweight/obesity.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with overweight/obesity

          2. Patients with normal weight as controls

        Exclusion Criteria:

          1. had ever been performed with a bariatric surgery before the study's first visit is
             scheduled;

          2. had taken exogenous insulin, medication that affects glucose metabolism, or uric acid
             drugs currently;

          3. being diagnosed with type 1 diabetes, secondary diabetes, hereditary disease, or
             severe disease (e.g. malignant tumor, heart failure, liver failure, etc.);

          4. in gestation of lactation;

          5. did not have the complete data for model;

          6. for normal-weight controls, patients with diabetes or hyperuricemia were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2020</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Shen Qu</investigator_full_name>
    <investigator_title>Clinical Professor and Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Machine learning</keyword>
  <keyword>Metabolic classification</keyword>
  <keyword>Clustering</keyword>
  <keyword>Bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

